Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Antiviral Chemistry & Chemotherapy|October 3, 2003
Probing the mechanistic consequences of 5-fluorine substitution on cytidine nucleotide analogue incorporation by HIV-1 reverse transcriptaseAdrian S Ray, Raymond F Schinazi, Eisuke Murakami, et al.Bioorganic & Medicinal Chemistry|November 11, 2008
C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitorsRoger Hunter, Yassir Younis, Clare I Muhanji, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseJuliana Ruiz-Caro, Aravind Basavapathruni, Joseph T Kim, et al.Biochemistry|January 28, 2016
Characterization of the Enzymatic Activity of SETDB1 and Its 1:1 Complex with ATF7IPAravind Basavapathruni, Jodi Gureasko, Margaret Porter Scott, et al.Antiviral Chemistry & Chemotherapy|June 5, 2007
Mechanism of action of (-)-(2R,4R)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl) thymine as an anti-HIV agentEisuke Murakami, Haiying Bao, Aravind Basavapathruni, et al.Journal of Virology|April 26, 2012
Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeysWendy W Yeh, Laura M Brassard, Caroline A Miller, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 20, 2015
Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic targetNigel J Waters, Scott R Daigle, Bruce N Rehlaender, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 2013
Bifunctional inhibition of HIV-1 reverse transcriptase: a first step in designing a bifunctional triphosphateDongyuan Piao, Aravind Basavapathruni, Pinar Iyidogan, et al.Journal of Virology|November 13, 2009
Envelope vaccination shapes viral envelope evolution following simian immunodeficiency virus infection in rhesus monkeysAravind Basavapathruni, Wendy W Yeh, Rory T Coffey, et al.Chemical Biology & Drug Design|September 18, 2012
Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1LAravind Basavapathruni, Lei Jin, Scott R Daigle, et al.Pageof 3